Key facts
- This page summarizes Carmen B. Volkart's Form 4 filing for Modular Medical, Inc. (MODD).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 01 Apr 2025, 17:00.
Carmen B. Volkart - 31 Mar 2025 Form 4 Insider Report for Modular Medical, Inc. (MODD)
- Reporting relationship
- Director
- Issuer ticker
- MODD
- Reported as of
- 31 Mar 2025
- Net transaction value
- +$688
- SEC form
- 4
- Accepted by SEC
- 01 Apr 2025, 17:00:12 UTC
- Prior SEC filing
- 03 Jan 2025
- Next SEC filing
- 09 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ James Sullivan, Attorney in Fact for Carmen Volkart
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Carmen B. Volkart filed Form 4 for Modular Medical, Inc. (MODD) on 01 Apr 2025.
Change
- Previous filing in this sequence was filed on 03 Jan 2025.
- Current net transaction value: +$688.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MODD
transaction
Common Stock
Award
- Transaction value
- $688
- Shares
- +625
- Change %
- +5.5%
- Price
- $1.10
- Shares after
- 12,085
- Date
- 31 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MODD
transaction
Derivative
Option to purchase common stock
Award
- Transaction value
- Shares
- +7,500
- Change %
- Price
- Shares after
- 7,500
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,500
- Exercise price
- $1.10
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.
Footnote F2
The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.
Footnote F3
In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."